Professor Alizadeh focuses on the architecture of research in the field of liquid biopsy technology as a method for monitoring lymphomas. The data examined relates to Hodgkin's and non-Hodgkin's diseases and the application of these tools for non-invasive tumor detection and genotyping for patient monitoring and risk assessment. He also hypothesizes about how these methods could be applied to therapy selection and improvement.
Professor Alizadeh focuses on the architecture of research in the field of liquid biopsy technology as a method for monitoring lymphomas. The data examined relates to Hodgkin's and non-Hodgkin's diseases and the application of these tools for non-invasive tumor detection and genotyping for patient monitoring and risk assessment. He also hypothesizes about how these methods could be applied to therapy selection and improvement.
ICML 16 - Lugano 2021 Virtual Edition
ICML 2021: vantaggi e svantaggi della modalità congressuale virtuale
I temi focali trattati a ICML 2021
Architecture of research in Lymphoma monitoring
Immune environment in the malignancy of Non-Hodgkin Lymphoma
CAR-T cells vs bispecific monoclonal antibodies in lymphoma therapy
Follicular Lymphoma: main vulnerabilities
New developments in Lymphoma radiotherapy
